New Delhi, 11/6 (AO Bureau):The outbreak of the delta variant responsible for the second wave of corona in India has subsided. NK Arora, head of the National Technical Advisory Group has said this. Along with this, Dr. Arora said that NTAGI is monitoring the gap in two doses of the vaccine and it will be reviewed in three to four months. Dr. Arora said, “We are looking at the time interval between doses of the vaccine and will review it after three to four months. As far as the outbreak of the delta variant in India is concerned, the bad phase has passed.” The Delta variant is also known as B.1.617.2. This strain of corona virus is believed to be responsible for the devastation in the second wave of infection in India.
The Delta variant has spread to more than 60 countries and for this reason the UK government had to reconsider its decision to unlock later this month. He said, “Break through infection in the case of covaccine vaccination is the same as the covishield vaccine. The proof of the vaccine’s effectiveness is the activation of antibodies in the body. But there are many T-cells too, which are not visible. We asked Bharat Biotech We have seen the clinical data for Phase 3 and believe that the data will be available and published soon.”
On immunization of children, NK Arora said that it is more likely that by the end of this year or early next year, the vaccination of children will start in the country. “Hopefully, the results of the trial on the age group of 2 to 18 will be published soon,” he said. He said that the cases of corona in the country are continuously decreasing. If we look at the initial data of the sero survey, there is a lot of infection, this means that we have an option to vaccinate faster.
Comments are closed.